GlassScriptPhysician profile
Ryan Reitano
NPI 1538654207
$1,302.18
in general payments reported to CMS, 2019-2025
10 companies · $13.45 in 2025
The $13.45 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2021: $14.25 · 2022: $513 · 2023: $459 · 2024: $156 · 2025: $13.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.28 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $797.96 | 2022-2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $141.55 | 2024 | Biohorizons |
| Straumann USA LLC | $125.97 | 2023 | |
| Tulsa Dental Products LLC | $88.45 | 2019 | |
| Dentsply Sirona INC | $58.65 | 2019 | |
| Align Technology, INC. | $33.34 | 2022 | |
| Envista Holdings Corporation | $14.38 | 2024 | Harmonize |
| 3m Company | $14.25 | 2021 | |
| Colgate Oral Pharmaceuticals, INC. | $14.18 | 2023 | |
| Voco America INC. | $13.45 | 2025 | Admira Fusion, Voco Profluorid Varnish, Meron Plus Qm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Reitano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.